MedPath

Synovial Fluid Sleep Study

Completed
Conditions
Sleep
Registration Number
NCT04688099
Lead Sponsor
NYU Langone Health
Brief Summary

This is an observational study of the relationship between perioperative sleep time/quality, synovial fluid cytokine profiles, and clinical outcomes of primary ACL reconstruction with BPTB autograft in 50 subjects. Sleep during the week before and month after surgery will be assessed using Fitbit smartwatch and sleep diary. Synovial fluid sampled preoperatively, intraoperatively, and postoperatively will be analyzed for levels of pro- and anti-inflammatory cytokines. Postoperative knee pain and function will be assessed until 2 years post-op using validated questionnaires.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  1. At least 18 years of age
  2. Undergoing primary ACL reconstruction with BPTB autograft for acute ACL tear, with or without concomitant meniscectomy
  3. Presenting within 2 weeks of injury and undergoing reconstruction within 8 weeks of injury
Exclusion Criteria
  1. History of blood-borne diseases including HIV, HBV, HCV, HTLV, or syphilis
  2. Pregnant
  3. Multiligamentous knee injury
  4. Concomitant meniscal repair, meniscal allograft transplantation, osteotomy, or repair of focal chondral defect (e.g., osteochondral autograft transfer system, osteochondral allograft, matrix-induced autologous chondrocyte implantation)
  5. Prior ipsilateral knee surgeries or injuries
  6. Primary sleep disorders including insomnia, sleep apnea, or restless legs syndrome
  7. Uncontrolled psychiatric disorders with sleep disturbance
  8. Night shift work
  9. Travel with time zone change within three weeks of surgery
  10. Systemic inflammatory disease
  11. Autoimmune disease
  12. Immunomodulatory drug use
  13. Chemotherapy within a year before surgery
  14. Intra-articular injection within 3 months before surgery

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Knee injury and Osteoarthritis Outcome Score (KOOS)Year 2

KOOS is a survey is meant to track how the participant feels about their knee and how well they are able to perform their usual activities. There are six categories in the survey: Symptoms, Stiffness, Pain, Function/Daily Living, Function/Sports, Quality of Life.

1. Symptoms category consists of 5 questions, ranked from "never" to "always" (0-5).

2. Stiffness category consists of 2 questions, ranked from "none" to "extreme" (0-5).

3. Pain category consists of 9 questions, ranked from "none" to "extreme" (0-5).

4. Function/Daily Living category consists of 17 questions, ranked from "none" to "extreme" (0-5).

5. Function/Sports category consists of 5 questions, ranked from "none" to "extreme" (0-5).

6. Quality of Life category consists of 4 questions, ranked from "not at all" to "extremely, constantly, totally" (0-5).

The total range of score is 0-210. The lower the score, the better they feel about their knee and performance of usual activities.

Secondary Outcome Measures
NameTimeMethod
Score on Lysholm Knee Scoring ScaleYear 2

The Lysholm Knee Scoring Scale consists of 35 common complaints which people frequently have with their knee problems. Participants will check each statement which best describes their condition -- each statement is assigned a particular score, and those scores are added together to obtain the total score out of 100 (total range: 0-100). A higher score indicates more knee problems.

Knee Range of MotionYear 1

Knee range of motion (maximal flexion and extension) will be measured bilaterally using a goniometer.

Thigh CircumferenceYear 1

Thigh circumference will be measured bilaterally.

Concentration of Synovial Fluid CytokinesYear 1

Synovial fluid from the injured knee will be sampled preoperatively, intraoperatively, and postoperatively and analyzed for levels of the following pro- and anti-inflammatory cytokines using multiplex magnetic bead immunoassay or ELISA: matrix metalloproteinase (MMP) 3, tissue inhibitor of metalloproteinase (TIMP) 1, TIMP-2, interleukin-1 receptor antagonist (IL-1ra), IL-6, monocyte chemotactic protein (MCP) 1, macrophage inflammatory protein (MIP) 1beta/CCL4, RANTES (regulated upon activation, normal T cell expressed and secreted), vascular endothelial growth factor (VEGF), and basic fibroblast growth factor (bFGF/FGF-2).

VAS Score for Anterior Knee PainYear 2

The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" and "worst pain." The total score range is 0-10; the higher the score, the worse the pain.

Trial Locations

Locations (1)

NYU Langone Health

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath